US President Trump's administration is readying to impose tariffs of 100% on certain medicines as it pushes pharmaceutical companies to manufacture more in the US, according to FT

The potential imposition of 100% tariffs on certain medicines by the Trump administration signals a significant escalation in trade policy, particularly aimed at reshoring pharmaceutical manufacturing.

Newsquawk StaffPublished On the live feed at 1 more headline followed before this page went public
Newsquawk headlinesUTC

[MARKET ANALYSIS] DXY strengthens amid higher oil and firmer yields after Trump's speech dampened Iran war off-ramp hopes

JD.com (9618 HK) along with 100 other appliance brands, plan CNY 10bln of trade-in subsidies

US President Trump's administration is readying to impose tariffs of 100% on certain medicines as it pushes pharmaceutical companies to manufacture more in the US, according to FT

[MARKET ANALYSIS] T-not futures declined as higher oil prices stoked inflationary concerns post-Trump speech

[MARKET ANALYSIS] Oil rallied and gold sold off after US President Trump's tough talk during the primetime address

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This move could foster inflationary pressures in the healthcare sector and contribute to volatility in related equities and forex pairs, especially as it may provoke retaliatory measures from trade partners. Market participants should prepare for potential shifts in sentiment across risk assets and safe havens as the situation evolves.

Related headlines

The whole workspace, free to try.

Try it free